Lemaitre Vascular (LMAT) Total Non-Current Liabilities (2010 - 2026)

Lemaitre Vascular's (LMAT) quarterly Total Non-Current Liabilities came in at $221.6 million in Q1 2026, up 6.76% year-on-year from $207.6 million in Q1 2025, and little changed on a QoQ basis from $220.7 million in Q4 2025.

Lemaitre Vascular (LMAT) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends

Lemaitre Vascular (LMAT) has 17 years of Total Non-Current Liabilities data on file, last reported at $221.6 million in Q1 2026.

  • On a quarterly basis, Total Non-Current Liabilities rose 6.76% year-over-year to $221.6 million in Q1 2026; TTM through Mar 2026 was $221.6 million, a 6.76% increase from a year earlier, with the FY2025 full-year figure at $220.7 million, up 3.28% from the prior year.
  • Total Non-Current Liabilities for Q1 2026 stood at $221.6 million, roughly flat from $220.7 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for LMAT reached as high as $221.6 million in Q1 2026 and fell as low as $33.9 million in Q1 2022.
  • Historically, Total Non-Current Liabilities has averaged $103.1 million across 5 years, with a median of $44.9 million in 2024.
  • Across the five-year window, Total Non-Current Liabilities sank 51.37% in 2022 and soared 417.24% in 2025, its largest moves.
  • Year by year, Total Non-Current Liabilities stood at $40.1 million in 2022, then climbed by 16.21% to $46.6 million in 2023, then jumped by 358.48% to $213.7 million in 2024, then increased by 3.28% to $220.7 million in 2025, then grew by 0.4% to $221.6 million in 2026.
  • Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $221.6 million in Q1 2026, $220.7 million in Q4 2025, and $218.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn 6.48 Bn
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn 1.92 Bn
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn 48.37 Bn
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn 17.13 Bn
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn 941.16 Mn
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn 996.30 Mn
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn 4.24 Bn
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn 8.65 Bn
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn 2.06 Bn
10 Lemaitre Vascular 2.22 Bn 1.86 Bn 48.40 Mn 221.59 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 221.59 Mn
Dec 31, 2025 220.71 Mn
Sep 30, 2025 218.21 Mn
Jun 30, 2025 213.97 Mn
Mar 31, 2025 207.56 Mn
Dec 31, 2024 213.70 Mn
Sep 30, 2024 45.69 Mn
Jun 30, 2024 41.37 Mn
Mar 31, 2024 44.86 Mn
Dec 31, 2023 46.61 Mn
Sep 30, 2023 43.23 Mn
Jun 30, 2023 42.06 Mn
Mar 31, 2023 40.51 Mn
Dec 31, 2022 40.11 Mn
Sep 30, 2022 38.40 Mn
Jun 30, 2022 40.70 Mn
Mar 31, 2022 33.90 Mn
Dec 31, 2021 38.51 Mn
Sep 30, 2021 40.29 Mn
Jun 30, 2021 60.54 Mn